JP2007500706A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500706A5
JP2007500706A5 JP2006522022A JP2006522022A JP2007500706A5 JP 2007500706 A5 JP2007500706 A5 JP 2007500706A5 JP 2006522022 A JP2006522022 A JP 2006522022A JP 2006522022 A JP2006522022 A JP 2006522022A JP 2007500706 A5 JP2007500706 A5 JP 2007500706A5
Authority
JP
Japan
Prior art keywords
alkyl
ethyl
group
yloxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522022A
Other languages
English (en)
Japanese (ja)
Other versions
JP4726238B2 (ja
JP2007500706A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024309 external-priority patent/WO2005012297A1/en
Publication of JP2007500706A publication Critical patent/JP2007500706A/ja
Publication of JP2007500706A5 publication Critical patent/JP2007500706A5/ja
Application granted granted Critical
Publication of JP4726238B2 publication Critical patent/JP4726238B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006522022A 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用 Expired - Fee Related JP4726238B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49071003P 2003-07-28 2003-07-28
US60/490,710 2003-07-28
PCT/US2004/024309 WO2005012297A1 (en) 2003-07-28 2004-07-27 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators

Publications (3)

Publication Number Publication Date
JP2007500706A JP2007500706A (ja) 2007-01-18
JP2007500706A5 true JP2007500706A5 (https=) 2007-09-20
JP4726238B2 JP4726238B2 (ja) 2011-07-20

Family

ID=34115427

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006522022A Expired - Fee Related JP4726238B2 (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用
JP2006521973A Pending JP2007500703A (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006521973A Pending JP2007500703A (ja) 2003-07-28 2004-07-27 ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用

Country Status (28)

Country Link
US (2) US20050043379A1 (https=)
EP (2) EP1660491B1 (https=)
JP (2) JP4726238B2 (https=)
KR (2) KR101149379B1 (https=)
CN (2) CN1856490A (https=)
AR (2) AR045729A1 (https=)
AT (2) ATE403654T1 (https=)
AU (2) AU2004261610B2 (https=)
BR (2) BRPI0413072A (https=)
CA (2) CA2534212A1 (https=)
CY (1) CY1108560T1 (https=)
DE (2) DE602004015620D1 (https=)
DK (2) DK1660491T3 (https=)
ES (2) ES2311858T3 (https=)
HR (2) HRP20060039A2 (https=)
IL (1) IL173372A (https=)
MY (1) MY145080A (https=)
NO (2) NO20060771L (https=)
NZ (2) NZ544938A (https=)
PL (2) PL1660491T3 (https=)
PT (2) PT1660492E (https=)
RU (2) RU2359970C2 (https=)
SG (2) SG129449A1 (https=)
SI (2) SI1660492T1 (https=)
TW (2) TWI362383B (https=)
UA (2) UA87986C2 (https=)
WO (2) WO2005012296A1 (https=)
ZA (2) ZA200601720B (https=)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE403654T1 (de) * 2003-07-28 2008-08-15 Janssen Pharmaceutica Nv Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren
CA2603122A1 (en) * 2005-03-31 2006-10-05 Janssen Pharmaceutica N.V. Phenyl and pyridyl lta4h modulators
JP5154406B2 (ja) 2005-04-13 2013-02-27 アステックス、セラピューティックス、リミテッド 医薬化合物
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
CA2620127A1 (en) * 2005-09-02 2007-03-08 F. Hoffmann-La Roche Ag Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
JP5133889B2 (ja) * 2005-09-21 2013-01-30 デコード ジェネティクス イーエイチエフ 炎症治療のためのビアリール基置換複素環lta4h阻害剤
EP1963261A1 (en) 2005-12-21 2008-09-03 Decode Genetics EHF Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
CA2634699A1 (en) 2005-12-21 2007-06-28 Decode Genetics Ehf N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
CA2636929A1 (en) * 2005-12-21 2007-07-12 Decode Genetics, Ehf Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
LT1976828T (lt) * 2005-12-29 2017-04-25 Celtaxsys, Inc. Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス.エイ. カルシウムチャネルブロッカーとしての環状尿素化合物
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
CA2656057C (en) * 2006-06-16 2012-10-02 H. Lundbeck A/S Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
EP2066800A2 (en) * 2006-08-04 2009-06-10 Decode Genetics EHF Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
US8115005B2 (en) 2006-08-04 2012-02-14 Decode Genetics Ehf. Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
US7728032B2 (en) * 2006-08-04 2010-06-01 Decode Genetics Ehf Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
TW200906396A (en) * 2007-02-14 2009-02-16 Janssen Pharmaceutica Nv LTA4H modulators and uses thereof
JP2010520878A (ja) * 2007-03-08 2010-06-17 アイアールエム・リミテッド・ライアビリティ・カンパニー Gpr119活性の調節剤としての化合物および組成物
US20100100012A1 (en) * 2007-03-30 2010-04-22 Yoshihiro Matsumura Activity intensity measurement device
AR069126A1 (es) * 2007-10-31 2009-12-30 Janssen Pharmaceutica Nv Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
CA2705294C (en) * 2007-11-16 2016-05-17 Abbott Laboratories Methods of treating arthritis by the administration of substituted benzenesulfonamides
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
MY157597A (en) 2008-04-11 2016-06-30 Janssen Pharmaceutica Nv Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
PT2294066E (pt) 2008-04-28 2014-11-21 Janssen Pharmaceutica Nv Benzoimidazoles como inibidores da prolil-hidroxilase
US8399465B2 (en) * 2009-05-14 2013-03-19 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolase
CN102442961A (zh) * 2010-11-10 2012-05-09 江苏德峰药业有限公司 1-甲基四氮唑的生产方法
CN102442962A (zh) * 2010-11-10 2012-05-09 江苏德峰药业有限公司 1-烷基四氮唑的生产方法
WO2013063221A1 (en) 2011-10-25 2013-05-02 Janssen Pharmaceutica Nv Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
AU2014249168B2 (en) 2013-03-12 2018-07-12 Celltaxis, Llc Methods of inhibiting leukotriene A4 hydrolase
BR112015022864A8 (pt) 2013-03-14 2019-11-26 Celtaxsys Inc composto, composição farmacêutica e uso dos mesmos
CA2906035A1 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
WO2014152536A2 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
ME02896B (me) * 2013-12-17 2018-04-20 Lilly Co Eli Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4
US10752588B2 (en) 2014-12-19 2020-08-25 The Broad Institute, Inc. Dopamine D2 receptor ligands
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands
JP6549735B2 (ja) 2015-06-09 2019-07-24 アッヴィ・インコーポレイテッド 核内受容体調節剤
JP6931058B2 (ja) 2016-12-21 2021-09-01 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 抗体のインビトロ糖鎖工学における酵素の再使用
CN117887794A (zh) 2016-12-21 2024-04-16 豪夫迈·罗氏有限公司 用于体外糖工程化抗体的方法
CN107663192B (zh) * 2017-11-03 2019-05-10 梯尔希(南京)药物研发有限公司 一种雷贝拉唑杂质的制备方法
ES3014615T3 (en) 2018-05-31 2025-04-23 Celltaxis Llc Method of reducing pulmonary exacerbations in respiratory disease patients
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN113784713A (zh) * 2019-01-11 2021-12-10 纳吉斯制药股份有限公司 白三烯合成抑制剂
CN110026557B (zh) * 2019-05-28 2021-08-27 南方科技大学 一种混合固体颗粒重熔的直写装置及成型方法
BR112023009665A2 (pt) * 2020-11-19 2023-12-12 Telo Therapeutics Inc Compostos e composições de molécula pequena
US11932630B2 (en) * 2021-04-16 2024-03-19 Novartis Ag Heteroaryl aminopropanol derivatives
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
CN113735798B (zh) * 2021-09-27 2022-07-12 安徽美致诚药业有限公司 一种盐酸罗沙替丁醋酸酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873346A (en) * 1985-09-20 1989-10-10 The Upjohn Company Substituted benzothiazoles, benzimidazoles, and benzoxazoles
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
IT1240598B (it) * 1990-03-13 1993-12-17 Mini Ricerca Scient Tecnolog Derivati amminici ad azione antifungina
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
HUP0100156A3 (en) * 1998-02-25 2002-12-28 Genetics Inst Inc Cambridge Indole derivatives as inhibitors of phospholipase a2 and use of them for producing pharmaceutical compositions
US6514964B1 (en) * 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
US20040110757A1 (en) * 2002-03-21 2004-06-10 Thomas Arrhenius Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
ATE403654T1 (de) * 2003-07-28 2008-08-15 Janssen Pharmaceutica Nv Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren
US7541466B2 (en) * 2003-12-23 2009-06-02 Genzyme Corporation Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
EP1863476B1 (en) * 2005-03-16 2016-02-03 MEDA Pharma GmbH & Co. KG The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
TW200906396A (en) * 2007-02-14 2009-02-16 Janssen Pharmaceutica Nv LTA4H modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2007500706A5 (https=)
CA2534228A1 (en) Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
JP2007500703A5 (https=)
DE60017179T2 (de) Tyrosin kinaseinhibitoren
CN105143221B (zh) 用于治疗炎性障碍的化合物及其药物组合物
JP2009523816A (ja) 2−イミノ−ベンズイミダゾール類
JP2008520741A5 (https=)
JP2006503010A5 (https=)
US10189826B2 (en) Heterocyclic compounds and methods of use
JP2020531498A5 (https=)
JP2021506889A5 (https=)
JP2015523387A5 (https=)
JP2008513499A5 (https=)
CN1152870A (zh) 杂环化合物作为多巴胺d3配位体的用途
JP2010510224A (ja) ケモカイン受容体拮抗薬としてのアミノピロリジン類
KR20180099933A (ko) 복소환 아민 및 이의 용도
JP2007507511A5 (https=)
PT1581532E (pt) Compostos pirazolo[3,4-b]piridina e seu uso como inibidores de fosfodiesterase
JP2006524254A5 (https=)
JP2010513283A (ja) 新規なオキサジアゾール化合物
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
JP2001517652A5 (https=)
JP2018534328A5 (https=)
JP2009536196A5 (https=)
CA2605899A1 (en) Triazole derivatives as vasopressin antagonists